Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to -$119000.0.

  • P3 Health Partners' Cash from Investing Activities fell 10079.33% to -$119000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$544000.0, marking a year-over-year decrease of 10357.61%. This contributed to the annual value of $14.5 million for FY2024, which is 89501.92% up from last year.
  • P3 Health Partners' Cash from Investing Activities amounted to -$119000.0 in Q3 2025, which was down 10079.33% from $50000.0 recorded in Q2 2025.
  • P3 Health Partners' Cash from Investing Activities' 5-year high stood at $15.0 million during Q3 2024, with a 5-year trough of -$6.4 million in Q3 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$425500.0 (2023), whereas its average is -$207062.5.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 37142.86% in 2023, then skyrocketed by 397596.9% in 2024.
  • Over the past 5 years, P3 Health Partners' Cash from Investing Activities (Quarter) stood at -$324833.0 in 2021, then skyrocketed by 115.39% to $50000.0 in 2022, then skyrocketed by 324.0% to $212000.0 in 2023, then plummeted by 324.06% to -$475000.0 in 2024, then surged by 74.95% to -$119000.0 in 2025.
  • Its Cash from Investing Activities stands at -$119000.0 for Q3 2025, versus $50000.0 for Q2 2025 and -$475000.0 for Q4 2024.